[MOL] Drug Treatment for Breast, Ovarian Cancer Series [02823] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Drug Treatment for Breast, Ovarian Cancer Series



docetaxel 

Tradename Taxotere 
Manufacturer Rhone-Poulenc Rorer 
Treatment Class Oncology 
Indication Breast, Ovarian Cancer 
MSB Review: Semisynthetic Taxol Approved for Breast, Ovarian Cancer 
MSB Review: Topotecan Approved for Ovarian Cancer 
PNN Review Breast Cancer Symposium Opens in San Antonio 
DrugPR: RPR RECEIVES APPROVABLE LETTER FROM U.S. FDA FOR TAXOTERE(R)
(docetaxel) 
DrugPR: Study Indicates That New Anticancer Agent is Highly Effective and
Well-Tolerated in Advanced Head & Neck Cancer 
DrugPR: TAXOTERE(R)/NAVELBINE(R) COMBINATION THERAPY DEMONSTRATES PROMISING
ACTIVITY IN ADVANCED BREAST CANCER 
DrugPR: TAXOTERE(R) (docetaxel) APPROVED IN NORWAY FOR TREATMENT OF
ADVANCED BREAST CANCER 
DrugPR: TAXOTERE(R) (docetaxel) RECEIVES APPROVAL IN 15 COUNTRIES OF
EUROPEAN UNION (EU) FOR TREATMENT OF ADVANCED BREAST CANCER 
DrugPR: TAXOTERE(R) (docetaxel) RECEIVES APPROVAL IN 15 COUNTRIES OF
EUROPEAN UNION (EU) FOR TREATMENT OF ADVANCED BREAST CANCER 
DrugPR: Taxotere Plus Doxorubicin Shows Significant Activity in Metastatic
Breast Cancer - 15 Dec 98 
DrugPR: WOMEN WITH METASTATIC BREAST CANCER RESPOND TO TAXOTEREŽ IN
COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE - 15 Dec 98 

------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------